# China NMPA Product Recall - Trauma Surgical Instrument Kit

Source: https://www.globalkeysolutions.net/records/china_product_recall/synthes-gmbh/c05e6227-43fb-4323-999e-8c47a6e41156/
Source feed: China

> China NMPA product recall for Trauma Surgical Instrument Kit by Synthes GmbH published April 21, 2016. Recall level: Level II. Johnson & Johnson (Shanghai) Medical Devices Co., Ltd., representing manufacturer Synthes GmbH, init

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. voluntarily recalls trauma surgery instrument packs
- Company Name: Synthes GmbH
- Publication Date: 2016-04-21
- Product Name: Trauma Surgical Instrument Kit
- Recall Level: Level II
- Recall Reason: The manufacturer's investigation found that affected products may break when struck with a hammer during intramedullary nail insertion. If a doctor discovers a product breakage, the need for replacement in the operating room may delay surgery. If fragments remain in the patient's body, it may induce adverse tissue reactions, although these foreign body fragments are highly likely to be completely removed through thorough intraoperative irrigation and suction. No related adverse events have been reported in China.
- Discovering Company: Johnson & Johnson (Shanghai) Medical Devices Co., Ltd.
- Manufacturing Company: Synthes GmbH
- Summary: Johnson & Johnson (Shanghai) Medical Devices Co., Ltd., representing manufacturer Synthes GmbH, initiated a voluntary Class II recall for specific Trauma Surgical Instrument Kits (Model 357.012). This recall, reported to the National Medical Products Administration (NMPA) on March 2, 2016, and published on April 21, 2016, addresses a critical product defect. The main violation identified through a manufacturer's investigation is that these auxiliary surgical instruments may break when struck with a hammer during intramedullary nail insertion. This issue could lead to surgical delays if a replacement is needed, or, more seriously, the potential for fragments to remain within a patient’s body, inducing adverse tissue reactions. Although fragments are likely removable through intraoperative irrigation, the risk necessitated this action. No related adverse events had been reported in China. The regulatory framework for this recall falls under NMPA guidelines. Required actions included notifying affected customers to immediately stop using and return the products. All recalled units, including the 5 imported to China, are to be locally destroyed to prevent any further use.

Company: https://www.globalkeysolutions.net/companies/synthes-gmbh/77a06946-ba7a-4bf2-916a-600eabfb0ce7/